Nitric oxide, a mediator of inflammation, suppresses tumorigenesis

S Perwez Hussain1, Glennwood E Trivers, Lorne J Hofseth

  • 1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255, USA.

Cancer Research
|October 7, 2004
PubMed

Insights

Nitric oxide (NO*) production, regulated by NOS2 and p53, suppresses cancer development. Genetic studies in mice reveal that NO* deficiency accelerates lymphoma and sarcoma formation, highlighting its tumor-suppressive role.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Inflammation is a known driver of cancer development.
  • Nitric oxide synthase 2 (NOS2) produces nitric oxide (NO*), a key inflammatory mediator.
  • The tumor suppressor protein p53 regulates NO* production by inhibiting NOS2.

Purpose of the Study:

  • To investigate the cooperative roles of NO* and p53 in tumorigenesis using a genetic approach.
  • To determine if NO* and p53 interaction influences cancer development and progression.

Main Methods:

  • Cross-breeding of mice with specific genetic deficiencies in p53 and NOS2 (p53-/-NOS2-/-, p53-/-NOS2+/-, p53+/-NOS2-/-, p53+/-NOS2+/-).
  • Monitoring tumor development (lymphomas, sarcomas) in genetically modified mouse models.
  • Assessing spleen and thymus for apoptotic index, proliferation index, death receptor ligands (CD95-L, TRAIL), and p21(waf1) expression.
  • Measuring cytokine levels (interleukin 10) in deficient mice.

Main Results:

  • Lymphomas developed more rapidly in mice lacking functional NOS2 and/or p53 compared to controls.
  • Sarcomas and lymphomas also showed accelerated development in mice with combined p53 and NOS2 deficiencies.
  • Mice lacking both p53 and NOS2 exhibited increased anti-inflammatory interleukin 10 production.
  • p53-/-NOS2+/+ mice displayed higher apoptosis and lower proliferation with increased expression of death receptor ligands and p21(waf1) compared to double knockout mice.

Conclusions:

  • NO* plays a critical role in suppressing tumorigenesis.
  • p53 and NO* cooperate in regulating tumor development.
  • NO* deficiency exacerbates cancer progression, particularly in the context of p53 dysfunction.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...